Electricity is the future of transportation, powered by battery cells that are designed and manufactured by some of the brightest, most innovative people in the world. Ultium Cells is committed to using the most technologically advanced methods in the industry to produce the very best of those battery cells, now and for generations to come. But we need a team of forward-thinking folks with diverse skills and experiences to achieve that vision. We are looking for talented individuals ready to seize the opportunity to learn about and grow with the electric transportation industry.

Supply Chain Engineering Change Specialist

Inspection Engineer

Safety Specialist- Day Shift

Interpreter (Korean)

Production Supervisor

Equipment Technology Engineer

Ultium Cells LLC

Report: Ultium Cells Slows Construction on Third Plant

Gretchen Whitmer's Top Aide Helped Pass Funding for EV Battery Plants. Now He's a Top GM Lobbyist.

Ultium Cells workers in Lordstown ratify their first UAW contract

Ultium Cells open Tennessee battery plant after quarter-long delay

Kee Eun

President and CEO

Quality Inspector

Quality Specialist

Set-up Operator

Route Manager

Quality Control

Quality Technician

Service Room Lead/Maintenance

Bombardi Lead Person

QA Supervisor

QA Lead

Equipment Maintenance Team Leader

Production Maintenance

Journeyman Electrician

Multi-skill Maintenance

Maintenance Mechanic

Electrode Engineering Intern

Battery Intern

Undergraduate Research Assistant

Waiter

Retail Associate

Intern

Production Engineer

Tennessee Tech Undergraduate Researcher

Pharmacy Technician

Akamai

CSC Corporate Domains

Microsoft Office 365

SOASTA

Mobile Friendly

Bootstrap Framework

Production Process Engineer II

ECS is a Virginia-based company that provides services such as geotechnical engineering and construction materials testing for industries including healthcare and retail.

Database Administrator

Facilities Staff Project Manager

Environmental Project Manager - Industrial Hygiene (IH)

Geotechnical Staff Project Manager I

Construction Materials Staff Project Manager I

ECS Limited

ECS Group announces appointment of Hachemaoui as new Commercial Director for EFIS MAROC

Trey Hendrick Promoted to Director of Talent & Organizational Development

Kevin Jobes Joins ECS As Group Manager

Thomas Rebar Joins Morgantown Office as Environmental Senior Project Manager

Tony Fiorillo

President & CEO

Outlook

Google Cloud Hosting

Drupal

iCIMS

Google Font API

Quality Assurance Quality Control

Tennessee Tech is an educational institution that offers undergraduate and postgraduate degree programs.

Federal Work Study Coordinator

Tennessee Technological University

Tennessee Tech faculty earn $3 million grant to train future leaders on convergence
of energy, AI and cybersecurity

New director takes helm of the Cybersecurity Education, Research and Outreach Center
at Tennessee Tech

Local students named to Tennessee Tech Spring 2024 Dean's List

Tennessee Tech Launches New Degree Program in Nuclear Engineering

Alex Hatcher

VueJS

Jira

Atlassian Confluence

React Redux

Python

Formulation Scientist

President

Vice President

We are one of the leading generic pharmaceutical companies in Central Eastern Europe, our activities incorporate all areas of the pharmaceutical value chain. Egis is a member of Servier, a global pharmaceutical group governed by a Foundation.In the 2022/2023 business year Egis Group generated net sales of EUR 631.7 million. Besides Hungary, we sell our products under Egis' brand names in 18 countries through our network of subsidiaries and representative offices.Our products (active ingredients, tablets, injections, galenic formulations etc.) are available in 100 countries in total through our network of subsidiaries, representative offices or partners. Our focus lies on treating diseases of the cardiovascular and central nervous systems and we also provide modern treatment solutions in the fields of diabetology, skin and wound care. In 2013, we launched our first biosimilar monoclonal antibody (mAb) product, it was also the first mAb in the European Union. Since then, we launched 3 more biosimilar drugs.As one of the companies in the CEE region committed to innovation, we devote more than EUR 45 million yearly to R&D. Our research and development activities focus on high-quality, value-added branded generic products.In the last 20 years, we have invested more than EUR 770 million in improvements in Hungary: we modernized the complete process of finished product manufacturing and established state-of-the-art R&D centres. In Budapest the development of drugs substances and finished products having significant biological activity in very small doses has become possible and the comprehensive modernization of the traditional technology of active ingredient manufacturing has been completed. Large-scale developments at our site in Körmend: inauguration of a new galenic plant (Sept 2019); the major extension of the packaging plant was completed and capacity to manufacture special medicines - typically oncology products - was established (both 2021 autumn).

Egis Pharmaceuticals PLC

Egis Zrt. - Active ingredient production for other companies

Australian Olympic Committee to partner with Egis

Egis becomes an industry partner of Emirates Green Building Council

Egis to acquire Omrania creating a leadership position in engineering and architecture consultancy in Saudi Arabia

Csaba Poroszlai

Chief Executive Officer

Amazon CloudFront

Amazon Elastic Load Balancer

Amazon AWS

Drug Discovery, Synthetic Organic Chemist, Medicinal Chemistry

Teva Pharmaceuticals has been developing and producing medicines to help improve people's lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.  Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Site Quality Manager

Head of Finance

Associate Director, Pipeline Management APAC

Neuroscience Sales Specialist - Houston W, TX

Clinical Science Liaison - Mid Atlantic

Material Handler I - 3rd Shift (Sun-Fri, 10PM-6:30AM)

Teva Pharmaceuticals

Coronation Fund Managers Ltd. Makes New $1.33 Million Investment in Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Bellevue Group AG Invests $2.01 Million in Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Teva study questions treatment breaks for migraine prevention

New AJOVY(R) (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses

Agoston Kiss

Production Process Engineer II at Ultium Cells LLC

Agoston Kiss' Professional Contact Details

Agoston Kiss' Current Company Details

Ultium Cells LLC

Agoston Kiss' Work History and Education

Frequently Asked Questions about Agoston Kiss

What company does Agoston Kiss work for?

What is Agoston Kiss' role at Ultium Cells LLC?

What is Agoston Kiss' email address?

What is Agoston Kiss' business email address?

What industry does Agoston Kiss work in?

Who are Agoston Kiss' colleagues?

Colleagues at Ultium Cells LLC

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?